L-Aspara, comprising Asparaginase to treat acute lymphoblastic leukemia
Arechar healthcare announces the launch of L-Aspara (L-Asparaginase), to make the treatment of acute lymphoblastic leukemia more accessible to patients all over the world. Cancer has been one of the life-threatening diseases and has been the cause of lifestyle disturbances. Also, the incidence of cancer is growing all over the world due to many factors like unavailability of the right medicines, inaccessibility/unaffordability, etc. Addressing this issue, Arechar Healthcare has come forward and has launched the best cure for Acute Lymphoblastic Leukemia (ALL).
The active ingredient of L-Aspara is L-Asparaginase. It is on the World Health Organization's List of Essential Medicines.
L-Aspara is given directly into the vein, muscle, or under the skin.
It breaks down the amino acid known as asparagine without which the cancer cells cannot make protein.
“With the increasing incidence of cancer in our world, we strive to bestow the best life-saving drugs, keeping in mind the accessibility and affordability of the medicines we offer. Humanity comes from actions based on our beliefs, therefore we execute the humanitarian beliefs with such steps towards healthcare, specifically in the field of oncology,” said Mr. Harpreet Singh, Founder of Arechar Healthcare.
“Arechar has always taken valuable steps ahead to serve the patients with the best and high-quality medicines at a very honest range of prices, for serving patients is the ultimate goal of our company,” he added.
“With every little step towards achieving easy healthcare, we crave to manufacture the best and reliable life-saving drugs, for our mission is to make these medicines accessible to the patients in all the regions of the world,” said Mrs. Ruchika Rajbans, Co-Founder of Arechar Healthcare.
“I believe in achieving excellence through innovation” she added.
About Arechar Healthcare
Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few manufacturers possess the drive and determination that the Arechar Healthcare Team has displayed, ever since it started. Focussing on the accessibility and efficacy of life-saving drugs, Arechar Healthcare aims to strengthen the healing and treatment process, with a major focus on oncology care and other diseases that threaten human lives.
Related hot topics
Novartis PLUVICTO™ for Prostate Cancer Becomes the First Targeted Radioligand Therapy
Pluvicto is a targeted radioligand therapy for progressive PSMA-positive metastatic prostate cancer.
Arechar Healthcare provides independent and precise information about prescription drugs with the related news and press releases. This content is displayed for informational purposes only and is not intended to be an alternative for any medical advice/prescription or treatment. Do not delay or ignore any medical treatment owing to something you’ve read or seen on this website. Also, this website offers links to other websites, enabling the viewers to directly switch to that website for detailed information or accurate references. Thus, Arechar is not responsible for the content displayed on the linked websites or the content of the links in the linked website.